Variability in Declining Haloperidol and Reduced Haloperidol Plasma Concentrations upon Haloperidol Cessation-Reference-Cited by-同舟云学术

Variability in Declining Haloperidol and Reduced Haloperidol Plasma Concentrations upon Haloperidol Cessation

Published:1993-01 Issue:1 Volume:5 Page:57-62
ISSN:0114-2402
Container-title:Drug Investigation
language:en
Short-container-title:Drug Invest

Author:

Lin Shih-Ku,Chang Wen-Ho,Lam Y. W. Francis,Jann Michael W.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine,Pharmacology (medical)

Link

http://link.springer.com/content/pdf/10.1007/BF03259228.pdf

Reference32 articles.

1. American Psychiatric Association. DSM-III-R: Diagnostic and Statistical Manual of Mental Disorders, 3rd ed., revised. APA, Washington, DC, 1987

2. Bowen WD, Moses EL, Tolentino PJ, Walker JM. Metabolites of haloperidol display preferential activity at sigma opiate receptors compared to dopamine D-2 receptors. European Journal of Pharmacology 177: 111–118, 1990

3. Browning JL, Harrington CA, Davis CM. Quantification of reduced haloperidol and haloperidol by radioimmunoassay. Journal of Immunoassay 6: 45–66, 1985

4. Caccia S, Garattini S. Formation of active metabolites of psychotropic drugs. Clinical Pharmacokinetics 18: 434–459, 1990

5. Chakraborty BS, Hubbard JW, Hawes EM, McKay G, Cooper JK, et al. Interconversion between haloperidol and reduced haloperidol in healthy volunteers. European Journal of Clinical Pharmacology 37: 45–48, 1989

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surface treatment of 45 steel by plasma-arc melting;Surface and Coatings Technology;1997-05